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Background: Glycogen is a branched polysaccharide of glucose residues, consisting of α-1-4 glycosidic linkages
with α-1-6 branches that together form multi-layered particles ranging in size from 30 nm to 300 nm. Glycogen
spatial conformation and intracellular organization are highly regulated processes. Glycogen particles interact with
their metabolizing enzymes and are associated with a variety of proteins that intervene in its biology, controlling its
structure, particle size and sub-cellular distribution. The function of glycogen in adipose tissue is not well
understood but appears to have a pivotal role as a regulatory mechanism informing the cells on substrate
availability for triacylglycerol synthesis. To provide new molecular insights into the role of adipocyte glycogen we
analyzed the glycogen-associated proteome from differentiated 3T3-L1-adipocytes.
Results: Glycogen particles from 3T3-L1-adipocytes were purified using a series of centrifugation steps followed by
specific elution of glycogen bound proteins using α−1,4 glucose oligosaccharides, or maltodextrins, and tandem
mass spectrometry. We identified regulatory proteins, 14-3-3 proteins, RACK1 and protein phosphatase 1 glycogen
targeting subunit 3D. Evidence was also obtained for a regulated subcellular distribution of the glycogen particle:
metabolic and mitochondrial proteins were abundant. Unlike the recently analyzed hepatic glycogen proteome, no
endoplasmic proteins were detected, along with the recently described starch-binding domain protein 1. Other
regulatory proteins which have previously been described as glycogen-associated proteins were not detected,
including laforin, the AMPK beta-subunit and protein targeting to glycogen (PTG).
Conclusions: These data provide new molecular insights into the regulation of glycogen-bound proteins that are
associated with the maintenance, organization and localization of the adipocyte glycogen particle.
Keywords: Glycogen, Glycogen-associated proteins, 3T3-L1 adipocytes, Proteomics, 14-3-3 proteins, Protein
phosphatase 1 regulatory subunit 3DBackground
Glycogen is a large intracellular particle consisting of a
glycogenin core-protein and a branched glucose polysac-
charide covalently attached to a C-1-O-tyrosyl linkage at
tyrosine 194 [1]. The α1,4 glucosidic polymer consists
primarily of oligosaccharides of 10 to 14 residues in
length linked to other oligosaccharides via α1,6 branch
points. The resulting three-dimensional structure con-
tains up to 12 oligosaccharide ‘layers’ with 50 to 60
thousand glucose residues and a final mass of about 107
Da [2]. Glycogen comprises smaller glycogen β particles* Correspondence: glendon.parker@uvu.edu
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reproduction in any medium, provided the or20–50 nm in diameter, depending on the tissue, and can
also form much larger rosettes denoted α particles (100–
300 nm in diameter) [3,4]. The function of glycogen is
to efficiently store and release glucose monosaccharides
in a manner that is rapidly accessible to the metabolic
and synthetic requirements of the cell [2,5].
Glucose flux into and out of the polysaccharide is con-
trolled by a combination of substrate availability and
regulation of catalytic activities, particularly the rate-
limiting enzymes glycogen synthase and glycogen phos-
phorylase [2]. Control of glycogen branching structure,
necessary for prolonged unidirectional glucose flux, is
controlled by both glycogen branching enzyme and
glycogen debranching enzyme. In addition to catalytic
activity, each of these enzymes also has carbohydrate
binding activity, containing glycogen or starch-binding
domains known as carbohydrate binding modulesral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ide, therefore, physically associates with all of the pri-
mary enzymes controlling initiation and dynamic
turnover of the particle [6-9]. In addition, regulatory
proteins such as phosphorylase kinase, laforin, and pro-
tein phosphatase 1 glycogen-targeting subunits are also
documented to specifically interact with the glycogen
polysaccharide [10-12]. The resulting carbohydrate /
protein complex therefore has all of the ingredients to
control glucose flux into or out of the molecule,
matching the physiological context of the cell or organ-
ism [10,13,14].
The release of glucose from intracellular sources com-
plements the elaborate mechanisms of glucose transport
into the cell. Together both glucose sources control the
concentration of glucose-6-phosphate (G6P), which in-
fluences flux into major metabolic and synthetic path-
ways. Because of its central role in cellular glycogen
metabolism is subject to sophisticated, redundant and
coordinated kinase signaling pathways. The effects of
this regulation are modulated by allosteric factors, par-
ticularly the upstream substrate G6P, but also AMP and
ATP. Additional regulatory mechanisms, such as O-
linked N-acetylglucosamine (O-GlcNAc), 14-3-3 pro-
teins, ubiquitination, and glycogen phosphorylation have
also been identified [9,15-17].
Glycogen metabolism is spatially regulated [18,19]. Elec-
tron microscopic studies have demonstrated association
of glycogen particles with subcellular structures, such as
the sarcoplasmic reticulum, the smooth endoplasmic
reticulum, other endoplasmic membranes, mitochondria,
cytoskeletal elements, and the plasma membrane [18].
The association of glycogen with these structures is dy-
namic [7]. Recent data have demonstrated a finer sub-
organelle control of glycogen localization [19]. There is
also physiological evidence of spatial regulation. Glucose
channeling into glycogen from gluconeogenesis is more
efficient than glucose transported from extracellular
sources, indicating that pools of G6P from intracellular
sources are more likely to spatially overlap with the glyco-
gen particle [24-26]. The high number of kinase pathways,
additional modes of regulation of glycogen metabolic en-
zymes, and evidence of fine spatial organization of the
glycogen particle, together suggest the potential for identi-
fication of additional regulatory proteins of glycogen me-
tabolism. We hypothesize that a systematic proteomic
analysis of glycogen-associated proteins will identify these
proteins.
Adipose tissue is a primary site for energy provision
via the hydrolysis of stored triglyceride to release free
fatty acid (FFA) for ATP production and glycerol for
hepatic gluconeogenesis in addition to being the storage
site for dietary lipid. Postprandial glucose is stored as
glycogen in the liver and used as an energy source inperipheral tissues but in adipocytes is for de novo lipo-
genesis and long-term storage as triglyceride. However,
adipocytes also store glucose as glycogen, albeit at sub-
stantially lower rates than in skeletal muscle and liver
[27]. The main role for adipose tissue glycogen is be-
lieved to yield precursors for glycerol formation espe-
cially following a period of fasting where glycogen
synthesis increases prior to lipid deposition [28]. This
spike in glycogen synthesis is believed to provide sub-
strate for the expansion of adipose mass [29]. However,
the involvement of glycogen stores during either obesity
or insulin resistance has not been determined. Given the
importance of adipocyte glycogen in lipid synthesis we
hypothesized that the adipocyte glycogen proteome
would include specialized regulatory proteins not found
in the liver glycogen proteome whose primary function
is to store and breakdown glycogen for the maintenance
of blood glucose levels.
In this study we purified glycogen particles from differ-
entiated 3T3-L1-adipocytes. Unlike adipose tissue that
has low levels of glycogen, 3T3-L1-adipocytes have high
levels of glycogen, are metabolically responsive, and are
amenable to in vitro manipulation [15]. We purified
glycogen particles using a series of centrifugation steps
followed by specific elution of glycogen bound proteins
using α1,4 glucose oligosaccharides, or maltodextrins.
Several regulatory proteins were identified, including 14-
3-3 proteins, RACK1 and protein phosphatase 1 glyco-
gen targeting subunit 3D. Evidence was also obtained for
a regulated subcellular distribution of the glycogen par-
ticle: metabolic and mitochondrial proteins were abun-
dant. Unlike the recently analyzed hepatic glycogen
proteome, no endoplasmic proteins were detected [19].
Other regulatory proteins, which have previously been
described as glycogen-associated proteins, were not
detected, including laforin, AMP-activated protein kinase
(AMPK) and protein targeting to glycogen (PTG) [30-32].
We also note that a population of glycogen synthase binds
with high affinity to the glycogen particle, even in the
presence of high concentrations of malto-oligosaccharides.
Together these data provide a proteomic context for ana-
lysis of potential and established regulatory mechanisms
and further elucidate the role of adipocyte glycogen me-
tabolism in cellular energy homeostasis.
Results and discussion
Isolation and processing of glycogen particles
Glycogen-associated proteins from mouse 3T3-L1-adipo-
cytes were isolated after repeated centrifugation steps,
which were sufficient to obtain a stable protein population
associated with the glycogen pellet (Figure 1). The prepar-
ation was then treated with malto-oligosaccharides, which
are identical to the α1,4 glucose oligosaccharide component
of glycogen molecules. This treatment disrupted specific
Ext P1 P2 P3 SN3
MO
Figure 1 Purification of the adipocyte glycogen protoeme.
Differentiated 3T3-L1 adipocytes were treated for 24 h with 2.5 mM
glucose and 10 mM glucosamine, collected, freeze / thawed,
sonicated and the 20 000 g supernatant (Ext) centrifuged at 400
000 g for 30 min. The glycogen pellet (P1) was resuspended and the
process was repeated. The second glycogen pellet (P2) was
resuspended in 50 mg malto-oligosaccharide (MO) / ml. The MO
supernatant (SN3), or soluble fraction, was the reference preparation
of glycogen-associated proteins used in this study. The MO pellet
(P3), or insoluble fraction, was also trypsinized to provide a control
comparative dataset to allow analysis of the stringency of the
purification. The proteins illustrated above are a representative
purification. Total amounts applied to the coomassie-G250 stained
SDS-PAGE above, are 0.05% (Ext) or 2% (P1, P2, P3 and SN3) of the
total sample.
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the glycogen polysaccharide resulting in solubilization
(SN3, Figure 1). The dominant bands remaining in the
pellet, which were not solubilized by the malto-
oligosaccharide treatment, were determined to be muscle
glycogen synthase by immunoblotting (data not shown).
A total of 6 preparations of glycogen-associated pro-
teins, representing biological replicates, were specifically
solubilized with malto-oligosaccharides, trypsinized and
analyzed by reversed-phase liquid chromatography /
mass spectrometry / mass spectrometry (LC/MS/MS).
All resulting datasets (n = 6) containing collision-
induced dissociation (CID) spectra were concatenated
and analyzed using the MASCOT software algorithm
(http://www.matrixscience.com), the PROWL search en-
gine (http://prowl.rockefeller.edu) and UNIPROT data-
base (http://www.uniprot.org). Identified gene products
that contained at least 2 unique peptide sequences with
expectation values less than 0.05 are listed functionally
in order of likelihood of identification (Table 1), with a
complete listing in the Supplemental section (Additional
file 1: Table S1). This dataset was analyzed two ways: byfunction (Table 1) and subcellular distribution (Figure 2).
The individual (n = 6) datasets were compared to determine
the number of instances a particular protein was repeatedly
identified in the glycogen-associated population (Table 2).
To further evaluate and identify potentially contaminating
proteins, datasets from 3 pellets, after specific elution using
α1,4 glucose oligosaccharides, were concatenated and ana-
lyzed (Tables 3 and 4) [33,34].
Identification of glycogen-associated proteins
The proteomic methodology was validated by the consist-
ent and frequent identification of proteins previously
known to maintain and physically associate with the glyco-
gen particle [10,13,14,36]. For instance, all glycogen meta-
bolic enzymes were present: glycogen phosphorylase, brain
isoform (GP; Mowse score = 20722), glycogen synthase,
muscle isoform (GS; score = 7954), glycogen branching en-
zyme (GBE; score = 4302), glycogen debranching enzyme
(GDE; score = 3387), and glycogenin-1 (score = 1394)
[10,13,14,36]. The muscle isoform of glycogen phosphoryl-
ase (score = 3687) was also present, indicating that brain
and muscle GP are involved in the regulation of cytoplas-
mic glycogenolysis in these cells. Known regulatory pro-
teins were also identified, such as protein phosphatase 1
catalytic subunit (score = 76) and the glycogen targeting
subunit 3D (PPP1R6 also known as R6; score = 701).
Other known glycogen-associated proteins, such as laforin,
AMPK, and PTG were not detected [10]. The absence of
AMPK could be explained by the predominant expression
of the β1-subunit in adipose tissue, instead of the AMPK
β2-subunit that has a 10- to 30-fold increased affinity for
linear or branched oligosaccharides [31,40,41]. A single
peptide from starch-binding domain protein 1 (STBD1)
and phosphorylase kinase was detected, insufficient to
meet the criteria as a glycogen-associated protein in this
analysis (data not shown). Glycogenin-1 was relatively
abundant indicating that a population of this protein was
accessible during trypsin digestion [42]. Glycogenin-1 is
necessary for initiating glycogen synthesis and therefore is
located at the center of each glycogen particle [2]. Associ-
ation of glycogenin-1 with the outer surface, as shown in
this study and in another study on the hepatic glycogen
proteome, was therefore unexpected [19]. Lysosomal
alpha-glucosidase was also identified in the data set (score =
102). This enzyme is necessary for the lysosomal degrad-
ation of the glycogen particle and is the gene product that
accounts for Glycogen Storage Disease II (or Pompe’s
disease) [43,44].
A predominant glycogen targeting regulatory subunit of
phosphatase I was identified in the study, PPP1R6 (or 3D)
(Table 1), found previously associated with glycogen from
skeletal muscle [45]. The presence of PPP1R6 in adipocytes
is a new finding and may suggest an important role for this
PP1 targeting subunit in the adipocyte. Unexpectedly, the
Table 1 The adipocyte glycogen proteome
Name ID Score Total # % E-value EmPAI:
Glycogen
Glycogen phosphorylase, brain form PYGB_MOUSE 20722 599 55 56.5 3.70E-10 17.06
Glycogen synthase, muscle Q8VEB0_MOUSE 7954 283 39 57.2 8.50E-09 7.67
Glycogen branching enzyme GLGB_MOUSE 4302 141 28 37.0 2.20E-08 4.30
Glycogen phosphorylase, muscle form PYGM_MOUSE 3687 138 16(1) 18.3 5.30E-02 1.11
Glycogen debranching enzyme* GDE_RABIT 3387 115 20 14.9 9.10E-09 0.67
Glycogenin-1 GLYG_MOUSE 1394 49 9 22.3 1.40E-06 2.17
Protein phosphatase 1, regulatory subunit 3D (or R6) A2AJW4_MOUSE 701 17 4 15.1 4.80E-08 0.55
Lysosomal alpha-glucosidase LYAG_MOUSE 102 2 2 2.9 5.30E-06 0.07
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit PP1A_MOUSE 76 3 2 8.8 6.50E-04 0.24
Metabolism
Glyceraldehyde-3-phosphate dehydrogenase G3P_MOUSE 1311 42 10 42.6 1.20E-07 2.01
Pyruvate carboxylase PYC_MOUSE 1182 31 11 12.3 1.60E-08 0.40
Malate dehydrogenase MDHM_MOUSE 827 16 4 20.4 2.90E-09 0.49
ATP synthase subunit beta ATPB_MOUSE 619 16 9 24.5 3.90E-08 0.94
Aldehyde dehydrogenase ALDH2_MOUSE 513 15 3 7.5 4.00E-07 0.22
ATP synthase subunit alpha ATPA_MOUSE 441 17 7 17.5 2.30E-05 0.62
L-lactate dehydrogenase A chain LDHA_MOUSE 438 7 3 14.5 4.20E-10 0.34
Alpha-enolase ENOA_MOUSE 424 10 4 14.1 2.10E-07 0.36
Aconitate hydratase ACON_MOUSE 368 7 3 6.7 1.70E-09 0.14
Acetyl-CoA acetyltransferase THIL_MOUSE 343 12 2 14.1 1.00E-09 0.17
(14 other proteins)
RNA
Cleavage and polyadenylation specificity factor subunit 6 CPSF6_MOUSE 928 16 6 15.8 9.80E-09 0.41
Putative RNA-binding protein Luc7-like 2 LC7L2_MOUSE 633 21 6 18.8 5.10E-07 0.61
Cisplatin resistance-associated overexpressed protein CROP_MOUSE 529 12 3 17.4 3.40E-08 0.48
Splicing factor, arginine/serine-rich 3 SFRS3_MOUSE 492 16 4 36.3 1.20E-04 2.38
Elongation factor 1-alpha 2 EF1A2_MOUSE 461 15 5 11.5 6.90E-07 0.43
Splicing factor U2AF 65 kDa subunit U2AF2_MOUSE 460 20 5 19.6 3.20E-05 0.40
Putative RNA-binding protein Luc7-like 1 LUC7L_MOUSE 384 15 3(1) 10.2 3.70E-06 0.32
ATP-dependent RNA helicase DDX3X DDX3X_MOUSE 361 8 4 8.9 1.10E-07 0.28
Cleavage and polyadenylation specificity factor subunit 5 CPSF5_MOUSE 361 16 6 36.1 6.80E-08 1.57
Pre-mRNA-splicing factor 38B PR38B_MOUSE 299 9 4 6.8 4.70E-07 0.25
(7 other proteins)
Regulatory proteins
14-3-3 protein gamma 1433G_MOUSE 795 32 9 33.7 3.90E-07 2.55
14-3-3 protein beta/alpha 1433B_MOUSE 554 27 10(4) 40.8 1.30E-05 2.56
14-3-3 protein zeta/delta 1433Z_MOUSE 488 23 6 26.5 7.90E-04 1.16
14-3-3 protein theta 1433T_MOUSE 265 15 4(1) 14.8 5.40E-05 0.70
14-3-3 protein epsilon 1433E_MOUSE 244 14 3(1) 12.9 2.00E-03 0.49
Receptor of activated protein kinase C 1 GBLP_MOUSE 212 7 2 6.3 6.50E-06 0.23
Ribosomes
40S ribosomal protein SA RSSA_MOUSE 377 8 2 9.5 4.00E-06 0.24
40S ribosomal protein S16 RS16_MOUSE 278 10 4 24.0 1.30E-05 1.34
40S ribosomal protein S18 RS18_MOUSE 265 10 5 25.7 2.20E-05 1.68
40S ribosomal protein S7 RS7_MOUSE 224 9 2 10.3 9.80E-06 0.38
Nucleolin NUCL_MOUSE 217 5 3 6.1 7.30E-07 0.15
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Table 1 The adipocyte glycogen proteome (Continued)
40S ribosomal protein S2 RS2_MOUSE 214 7 3 11.9 2.60E-05 0.41
40S ribosomal protein S4, X isoform RS4X_MOUSE 186 5 2 9.9 1.10E-05 0.27
40S ribosomal protein S24 RS24_MOUSE 184 6 2 20.3 5.20E-05 0.57
40S ribosomal protein S8 RS8_MOUSE 182 5 2 12.5 9.80E-05 0.34
40S ribosomal protein S13 RS13_MOUSE 150 5 3 24.5 1.30E-04 0.84
(12 other proteins)
Miscellaneous
Major vault protein MVP_MOUSE 1271 41 13 23.9 1.30E-07 0.69
Histone H2B type 1-B † H2B1B_MOUSE 881 17 3 27.2 2.00E-09 1.73
Stress-70 protein GRP75_MOUSE 789 28 7 13.8 3.00E-06 0.41
Histone H2A type 1-F† H2A1F_MOUSE 556 19 3 43.8 6.80E-07 1.67
60 kDa heat shock protein CH60_MOUSE 343 12 7 14.1 8.00E-07 0.63
Histone H1.2 † H12_MOUSE 291 10 4 15.1 3.90E-05 0.91
10 kDa heat shock protein CH10_MOUSE 238 4 2 19.6 9.50E-09 0.86
Histone H4 † H4_MOUSE 222 8 5 47.6 9.60E-06 3.51
Actin, alpha skeletal muscle ACTS_MOUSE 101 3 2 16.5 3.10E-04 0.19
Histone H2A.x † H2AX_MOUSE 95 6 3(1) 47.3 1.80E-02 1.11
Tubulin beta-2B chain TBB2B_MOUSE 93 3 3 11.0 1.20E-03 0.24
Proteins isolated from glycogen particles of mouse 3T3-L1 adipocytes were solubilized by malto-oligosaccharide treatment and trypsinized. Peptides were
desalted, purified, and analyzed by mass spectrometry (LC/MS/MS) and bioinformatic searches of the “mammalia” MSDB database. Mouse proteins, identified by
name and UNIPROT identifier (ID), that meet a significance level of less than 0.05 and with at least two different unique peptide sequences with expectation
scores less than 0.05, are listed functionally in order of likelihood by Mowse score (score). Other parameters include: the total number of peptides with
expectation scores less than 0.05 (total), number of different unique peptide sequences identified corresponding to the specific gene product (#), percent
coverage of the protein (%), and the lowest recorded expectation value (E-value) for a unique non-redundant peptide from the identified protein. In the case of
proteins with homology to other glycogen-associated proteins, the number of unique, non-redundant peptides is indicated in parentheses. Exponentially modified
Protein Abundance Index (emPAI) values are also included [35]. *The UniProt listing for GDE-MOUSE is not complete therefore the parameters presented
correspond to the closet match in the database, GDE_RABIT. †Insufficient data was obtained to conclusively match the identified peptides with a unique gene
product. A complete listing of proteins and parameters is located in the Supplemental section (Additional file 1: Table S1).
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Protein Targeted to Glycogen (PTG; or regulatory subunit
3C, or R5) [46,47]. RNAi-mediated reduction of PTG in
3T3-L1 adipocytes decreased glycogen accumulation, indi-














Figure 2 Cellular distribution of glycogen-associated proteins.
Proteins identified as glycogen-associated proteins, were submitted
to the UNIPROT database and the number of identified proteins in
each cellular and functional compartments obtained. Abbreviations
include: glycogen metabolic (g), cytoplasmic (c), mitochondrial (m),
nuclear (n), spliceosomal (s), ribosomal (r), and lysosomal
(ly) compartments.This is supported by studies in knockout mice, which ex-
hibit a phenotype of reduced adipose glycogen levels, al-
though there are different effects on glycogen metabolism
and insulin resistance [49] (Anna DePauli-Roach, personal
communication). As with other unexpectedly absent gene
products, such as laforin or AMPK, the possibility exists
that control over glycogen metabolism can be exerted by
proteins of low abundance, below the level of detection, or
by proteins that have low affinity for the glycogen particle.
Glycogen synthase was relatively resistant to solubilization
from the glycogen particle, with α1,4 glucose oligosacchar-
ide treatment, implying either that a structural form of
glycogen synthase has higher affinity for the particle or, al-
ternatively, glycogen synthase may bind to a motif that is
dissimilar to the α1,4 glucose oligosaccharide.
Many proteins with no documented role in glyco-
gen metabolism were also found to be associated
with glycogen (Table 1). The largest functional
group was metabolic enzymes not directly involved
in glycogen metabolism, with either mitochondrial
or cytoplasmic origins, the latter being primarily
glycolytic enzymes (24 total, Table 1). As anticipated,
given the cell source, some enzymes involved in
lipid metabolism were also detected, such as acetyl-
CoA acetyltransferase (THIL_MOUSE, Table 1).
Table 2 Repeated occurrence of proteins in the glycogen-associated proteome
Name Gene #
Glycogen phosphorylase, brain form PYGB_MOUSE 6
Glycogen branching enzyme GLGB_MOUSE 6
Glycogen synthase, muscle Q8VEB0_MOUSE 6
Glycogen debranching enzyme GDE_RABIT 5
Glycogenin-1 GLYG_MOUSE 4
Glyceraldehyde-3-phosphate dehydrogenase G3P_MOUSE 4
Histone H2B F H2B1_MOUSE 4
14-3-3 protein beta/alpha 1433B_MOUSE 3
Fatty acid synthase FAS_MOUSE 3
Aconitate hydratase, mitochondrial ACON_MOUSE 3
Malate dehydrogenase MDHM_MOUSE 3
Fatty acid-binding protein, adipocyte FABPA_MOUSE 3
Dihydrolipoamide acyltransferase (E2) Q8BMF4_MOUSE 3
60S acidic ribosomal protein P1 RLA1_MOUSE 3
Actin beta ACTB_MOUSE 3
GRP 75 GR75_RAT 3
60 kDa heat shock protein CH60_MOUSE 3
Major Vault Protein MVP_MOUSE 3
Isocitrate dehydrogenase subunit alpha, mitochondrial IDH3A_MOUSE 3
10 kDa chaperonin C Q9JI95_MOUSE 3
Keratin Kb40 Q6IFT3_MOUSE 3
Keratin, type II cytoskeletal 1b K2C1B_MOUSE 3
Keratin, type II cytoskeletal 1 K22E_MOUSE 3
Ribonuclease UK114 UK14_MOUSE 3
Trypsin - pig TRYP_PIG 3
Six preparations of mouse 3T3-L1 adipocyte glycogen-associated, malto-oligosaccharide solubilized proteins were trypsinized, desalted, purified, and analyzed by
mass spectrometry (LC/MS/MS). The resulting six datasets of fragmentation spectra were matched with peptide sequences using the MASCOT search algorithm
and the “Rodentia” MSDB database. The number of times that a protein, identified by name and UNIPROT identifier (ID), appeared in the six datasets is listed (#).
Identified proteins met a significance level of less than 0.05 and had at least two different unique peptide sequences with expectation scores less than 0.05.
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For example, receptor of activated protein kinase C 1
(RACK1) is a scaffolding protein that binds to protein
kinases and membrane-bound receptors in a regulated
fashion. It targets protein kinase C to ribosomes and
hypoxia-inducible factor 1 to the proteosome [50,51].
Five isoforms of 14-3-3 proteins were unambiguously
identified in this study. 14-3-3 proteins have a wide
range of regulated interaction with phosphoproteins,
contributing to many cellular processes including carbo-
hydrate metabolism [52,53]. The most abundant isoform,
14-3-3 gamma, has been linked to the development of
obesity in humans [54]. The beta-isoform of 14-3-3 is
also named protein kinase C inhibitor protein 1. This is
the first description of 14-3-3 proteins associating with
the glycogen particle. A recent analysis of the hepatic
glycogen proteome did not identify these regulatory pro-
teins, indicating a level of specificity for these proteins in
the adipocyte glycogen complex [19].Comparison of malto-dextrin soluble and insoluble
glycogen-associated protein populations
The purification of glycogen particles depends on a series
of ultracentrifuge steps, leaving open the possibility that
the presence of ribosomes, spliceosomes, and vault proteins
could be due to co-purification through co-precipitation
[55,56]. This is confirmed by the increased relative abun-
dance of these proteins in the glycogen pellet after the
malto-oligosaccharide treatment, potentially excluding
these proteins as part of the glycogen-associated population
(Tables 3 and 4).
The relative solubility, or insolubility, of proteins in
the presence of malto-oligosaccharides was estimated by
determining the relative abundance of each protein rela-
tive to glycogen phosphorylase [35]. The quotient of
these values provides a measure of specificity for binding
to the glycogen macromolecule. In Table 4, all proteins
that were relatively more soluble than glycogen phos-
phorylase, with a quotient greater than 1.00, were found
Table 3 Proteins present in glycogen pellet following specific elution with malto-oligosaccharides
Name ID Score Total # % E-value EmPAI
Glycogen synthase 1, muscle Q8VEB0_MOUSE 7920 254 29 41.7 8.20E-10 7.67
Glycogen phosphorylase, brain form PYGB_MOUSE 4197 122 23 33.8 2.70E-09 1.76
Glycogenin-1 GLYG_MOUSE 1360 39 7 21.7 1.40E-08 1.17
Splicing factor, arginine/serine-rich 3 SFRS3_MOUSE 1197 43 4 36.3 9.00E-06 3.31
Cisplatin resistance-associated overexpressed protein CROP_MOUSE 985 19 5 28.8 1.10E-08 0.93
Cleavage and polyadenylation specificity factor subunit 6 CPSF6_MOUSE 900 13 3 8.8 1.20E-10 0.26
Glyceraldehyde-3-phosphate dehydrogenase G3P_MOUSE 753 19 5 23.4 2.90E-07 0.65
Splicing factor U2AF 65 kDa subunit U2AF2_MOUSE 727 34 5 19.6 1.50E-06 0.60
Major vault protein MVP_MOUSE 726 25 11 16.6 2.50E-05 0.52
Putative RNA-binding protein Luc7-like 2 LC7L2_MOUSE 623 23 6 17 1.60E-06 0.61
ATP synthase subunit beta ATPB_MOUSE 620 16 6 17.7 1.90E-07 0.55
ATP-dependent RNA helicase DDX3X DDX3X_MOUSE 552 13 5 10.7 1.00E-07 0.35
ATP synthase subunit alpha ATPA_MOUSE 530 14 7 18.8 1.90E-06 0.53
Cleavage and polyadenylation specificity factor subunit 5 CPSF5_MOUSE 412 14 5 27.8 3.90E-08 1.58
Splicing factor, arginine/serine-rich 7 SFRS7_MOUSE 409 11 3(2) 22.3 1.30E-06 1.19
Histone H2A type 1-F † H2A1F_MOUSE 403 13 2 21.5 1.60E-07 1.09
Elongation factor 1-alpha 1 EF1A1_MOUSE 368 12 3 6.3 1.70E-07 0.24
Putative RNA-binding protein Luc7-like 1 LUC7L_MOUSE 355 16 3(1) 10.2 1.40E-02 0.32
Pre-mRNA-splicing factor 38B PR38B_MOUSE 348 14 3 6.8 3.80E-07 0.18
60 kDa heat shock protein CH60_MOUSE 323 8 3 8.3 3.90E-07 0.28
Histone H2B type 1-F/J/L † H2B1F_MOUSE 260 4 2 19.2 1.70E-09 0.66
Splicing factor U2AF 35 kDa subunit U2AF1_MOUSE 253 7 2 13 4.30E-05 0.29
Heterogeneous nuclear ribonucleoprotein H2 HNRH2_MOUSE 247 7 3(1) 9.6 6.40E-05 0.24
Stress-70 protein GRP75_MOUSE 242 6 3 6.3 2.80E-06 0.16
Heterogeneous nuclear ribonucleoprotein M HNRPM_MOUSE 234 7 35 8 1.20E-05 0.21
Trifunctional enzyme subunit alpha ECHA_MOUSE 226 7 4 8.7 2.50E-05 0.19
Histone H1t † H1T_MOUSE 213 6 2 10.5 1.90E-06 0.38
Vimentin VIME_MOUSE 163 3 2 5.2 1.10E-07 0.14
Probable ATP-dependent RNA helicase DDX5 DDX5_MOUSE 148 4 3(2) 4.3 6.70E-05 0.15
Probable ATP-dependent RNA helicase DDX17 DDX17_MOUSE 145 4 2(1) 3.5 9.90E-05 0.10
40S ribosomal protein S7 RS7_MOUSE 126 4 2 10.3 9.90E-06 0.38
60S ribosomal protein L23a RL23A_MOUSE 115 4 3 19.9 2.40E-04 0.81
Tubulin beta-2B chain † TBB2B_MOUSE 109 5 2 5.4 1.60E-02 0.24
Pyruvate carboxylase PYC_MOUSE 104 4 3 3.8 2.40E-04 0.09

















Table 3 Proteins present in glycogen pellet following specific elution with malto-oligosaccharides (Continued)
Glycogen debranching enzyme * Q8CE68_MOUSE 103 3 2(1) 1.9 2.90E-04 0.04
Ubiquitin UBIQ_MOUSE 87 3 3 44.7 1.60E-04 2.23
60S ribosomal protein L11 RL11_HUMAN 81 2 2 13.8 5.00E-05 0.45
ATP synthase subunit O ATPO_MOUSE 68 2 2 14.1 3.40E-03 0.35
Histone H4 † H4_MOUSE 64 2 2 19.4 3.40E-03 0.83
Proteins that were still present in the glycogen pellet after specific treatment with malto-oligosaccharides are listed (name and UNIPROT identifier (ID)) in order of likelihood of identification by Mowse score (score).
This population represents proteins whose physical interaction with the glycogen molecule is not disrupted by malto-oligosaccharide treatment either because of non-specific interaction with the particle or because
the specific interaction is not adequately competed with by the elution conditions used, 50 mg malto-oligosaccharide / ml. Other parameters included in the table are: the total number of unique non-redundant
peptide sequences identified (#), per cent coverage of identified proteins (%), and minimum expectation value for a unique non-redundant peptide from within the identified gene product (E-value). Exponentially
modified Protein Abundance Index (emPAI) values are also included [35]. Peptides with expectation scores above 0.05 were included in the analysis. All proteins listed have a minimum of two unique non-redundant

















Table 4 comparison of malto-oligosaccharide soluble and insoluble populations
Name ID Sol Insol Sol/insol Compartment
Glycogen-branching enzyme GLGB_MOUSE 0.25 0.03 7.39 g
Glycogen debranching enzyme * GDE_HUMAN 0.04 0.02 1.73 g
Protein phosphatase 1 regulatory subunit 3D A2AJW4_MOUSE 0.03 0.03 1.13 g
Glycogen phosphorylase, brain form PYGB_MOUSE 1.00 1.00 1.00 g
Pyruvate carboxylase PYC_MOUSE 0.02 0.05 0.46 m
Histone H4 † H4_MOUSE 0.21 0.47 0.44 n
Histone H2B type 1-F/J/L † H2B1F_MOUSE 0.15 0.38 0.40 n
Glyceraldehyde-3-phosphate dehydrogenase G3P_MOUSE 0.12 0.37 0.32 c
Stress-70 protein GRP75_MOUSE 0.02 0.09 0.26 m
Lysosomal alpha-glucosidase LYAG_MOUSE 0.00 0.02 0.24 g
60 kDa heat shock protein CH60_MOUSE 0.04 0.16 0.23 m
Probable ATP-dependent RNA helicase DDX17 DDX17_MOUSE 0.01 0.06 0.23 s
Glycogenin-1 GLYG_MOUSE 0.13 0.66 0.19 c
Probable ATP-dependent RNA helicase DDX5 DDX5_MOUSE 0.02 0.09 0.19 s
ATP synthase subunit beta ATPB_MOUSE 0.06 0.31 0.18 m
Cleavage and polyadenylation specificity factor subunit 6 CPSF6_MOUSE 0.02 0.15 0.16 s
Histone H2A type 1-F † H2A1F_MOUSE 0.10 0.62 0.16 n
Heterogeneous nuclear ribonucleoprotein H2 HNRH2_MOUSE 0.02 0.14 0.15 s
Pre-mRNA-splicing factor 38B PR38B_MOUSE 0.01 0.10 0.14 s
Major vault protein MVP_MOUSE 0.04 0.30 0.14 c
Heterogeneous nuclear ribonucleoprotein M HNRPM_MOUSE 0.02 0.12 0.13 s
ATP synthase subunit alpha ATPA_MOUSE 0.04 0.30 0.12 m
Glycogen synthase 1, muscle Q8VEB0_MOUSE 0.45 4.36 0.10 g
Tubulin beta-2B chain † TBB2B_MOUSE 0.01 0.14 0.10 c
ATP synthase subunit O ATPO_MOUSE 0.02 0.20 0.10 m
Putative RNA-binding protein Luc7-like 2 LC7L2_MOUSE 0.04 0.35 0.10 s
Putative RNA-binding protein Luc7-like 1 LUC7L_MOUSE 0.02 0.18 0.10 s
Cleavage and polyadenylation specificity factor subunit 5 CPSF5_MOUSE 0.09 0.90 0.10 s
Trifunctional enzyme subunit alpha ECHA_MOUSE 0.01 0.11 0.09 m
ATP-dependent RNA helicase DDX3X DDX3X_MOUSE 0.02 0.20 0.08 s
Splicing factor, arginine/serine-rich 3 SFRS3_MOUSE 0.14 1.88 0.07 s
Splicing factor U2AF 65 kDa subunit U2AF2_MOUSE 0.02 0.34 0.07 s
Cisplatin resistance-associated overexpressed protein CROP_MOUSE 0.03 0.53 0.05 s
The final purification of glycogen-associated proteins involved elution with malto-oligosaccharides, which competes with the glycogen molecule for specific
interactions with the glycogen-associated proteins. To provide a measure of specific interaction with the glycogen molecule, proteins common to both the malto-
oligosaccharide soluble and insoluble datasets were compared. Exponentially modified Protein Abundance Index (emPAI) values for each protein in the malto-
oligosaccharide soluble (sol) and insoluble (insol) datasets were divided by the emPAI value for glycogen phosphorylase, a reference protein known to specifically
interact with the glycogen molecule [10,35]. These relative measures of binding to the glycogen particle were then directly compared: sol / insol = ((emPAI of
protein in soluble dataset / emPAI of soluble glycogen phosphorylase) / (emPAI of protein in insoluble dataset / emPAI of insoluble glycogen phosphorylase)). This
calculation provides a measure of relative binding to the glycogen molecule and allows comparison between differently sized datasets. Proteins are listed in order
of relative solubility with malto-oligosaccharides (sol/insol). The reference protein, glycogen phosphorylase, is indicated in bold. Values greater than one represent
proteins that are relatively more soluble than glycogen phosphorylase. The subcellular localization of proteins common to both soluble and insoluble datasets is
also listed (compartment).
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http://www.proteomesci.com/content/11/1/11to be glycogen metabolic proteins. Glycogen synthase
and glycogenin were more associated with the glycogen
pellet than glycogen phosphorylase. These enzymes are
known to specifically interact with the glycogen particle
in a targeted manner. In this case, enrichment in the
glycogen pellet may have been due to the inability of
α1,4 glucose oligosaccharides to interact with andsolubilize these proteins. This population of totally α1,4
glucose oligosaccharide-solubilized proteins includes
regulatory proteins, the 14-3-3-isoforms, and RACK1.
This indicates that these proteins are candidates for a
population that specifically associates with the glycogen
protein / carbohydrate complex and potentially play a
role in protein regulation. This is the first description
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http://www.proteomesci.com/content/11/1/11of these proteins as candidate members of the glycogen
proteome.Sub-cellular distribution of glycogen-associated proteins
When subcellular locations of glycogen-associated proteins
are assigned, as annotated in the UNIPROT database
(http://uniprot.org), a distinctive distribution was observed
(Figure 2). Glycogen particles have been documented in the
cytoplasm, and with mitochondria, ribosomes, and endo-
plasmic and other membranes [10,13,19,21,57,58]. This cor-
responds to adipocyte glycogen-associated proteins that
derive predominantly from the cytoplasm, mitochondria, or
ribosomes. The population is also rich in nuclear proteins,
particularly spliceosomal proteins and histones, which we
do not consider to be specifically associated with the particle
(Table 4). The homogenization process disrupts the intracel-
lular architecture, physically disrupting the glycogen particle
along with attached, fragmented cellular structures. These
cytoskeletal elements, membranes and complexes with the
associated proteins would then co-purify.
There are no endoplasmic reticulum proteins present in
the adipocyte glycogen proteome (Figure 2). This is in
contrast to the hepatic glycogen-associated proteome,
where proteins associated with the endoplasmic reticulum
were highly abundant [19]. This was consistent with the
demonstration of starch binding domain protein-1
(STBD-1) (or genethonin-1) as a glycogen-associated pro-
tein in liver [19]. This protein contains a glycogen-binding
domain and an endoplasmic reticulum-targeting trans-
membrane domain, the predicted primary structure for a
protein mediating glycogen association with membranes
[34,59]. Only a single peptide of this protein was detected
in this analysis, insufficient for inclusion in this dataset.
The absence of endoplasmic reticulum-associated proteins
in the adipocyte glycogen population indicates that
targeting of glycogen to subcellular sites is different in dif-
ferent cell types [19,57,58,60,61]. In addition, STBD1 is
now thought to be involved in glycogen autophagy and
given that STBD1 is expressed in adipose tissue, the low
level of this protein in our proteomic data, only a single
peptide, suggests that adipose glycogen may not be de-
graded by this process2glycogen [2,63,64].Conclusion
The 3T3-L1 adipocyte glycogen proteome consists of en-
zymes essential for its synthesis together with specific regu-
latory proteins PPP1R6, RACK1 and the family of 14-3-3
protein isoforms, the most abundant of which have been
associated with obesity [64,65]. This is the first description
of the latter proteins as being potentially associated with
glycogen particles. Evidence of associating mitochondrial
proteins and a lack of endoplasmic reticulum proteins sug-
gest a different spatial arrangement of adipocyte glycogenparticles compared to hepatic glycogen particles. These
data provide new molecular insights into the relationship
of adipocyte glycogen metabolism with other cellular pro-
cesses and can be expanded to provide a starting point for
analyzing the glycogen proteome in adipose tissue from
animal models of Type 2 Diabetes and obesity. This will
lead to the identification of novel mechanisms and protein
activities that control the organization and deposition of
glucose metabolism as well as its integration into cellular
biosynthetic and metabolic pathways.Methods
Preparation and trypsinization of 3T3-L1 adipocyte
glycogen-associated proteins
3T3-L1 cells (American Type Culture Collection,
Manassas, VA) were differentiated into 3T3-L1-adipo-
cytes as described previously [15]. Adipocytes were treated
for 24 h in 10% fetal bovine serum, and 10 ml of DMEM
containing 10 Units of penicillin, 10 μg of streptomycin,
29.2 μg glutamine, 2.5 mM glucose and 10 mM glucosamine,
conditions that maximize glycogen accumulation and simu-
late energy repletion [15,66]. Cells were scraped and col-
lected in 750 μl of the extraction buffer (50 mM HEPES 7.4,
100 mM NaCl, 50 mM NaF and 50 μM O-(2-Acetamido-2-
deoxy-D-glucopyranosylidene) amino N-phenyl carba-
mate (PUGNAc)) (Toronto Research Chemicals, New
York, ON), frozen in liquid N2, thawed, sonicated for 15 -
seconds and centrifuged at 20 000 g for 2 min at 4°C. A
stock of 20 mg glycogen type-III / ml was added to the
supernatant to give a final concentration of 4 mg / ml, and
the sample was centrifuged in polycarbonate centrifuge
tubes at 400 000 g for 30 minutes in a Beckman Model
TLX 120 ultracentrifuge (Beckman-Coulter, Fullerton,
CA). The resulting tubes and pellets were carefully
cleaned using sterile cotton swabs and Nanopure water.
Pellets were then resuspended in extraction buffer and
recentrifuged at 400 000 g for 30 minutes at 4°C. The
third pellet preparations were resuspended in extraction
buffer and 200 mg α1,4 malto-oligosaccharides / ml was
added to give a final concentration of 50 mg / ml (MD-6
Calibrated Standard Maltodextrins, V-labs inc., Covington,
LA). The malto-oligosaccharide competes with the glycogen
molecule for binding to specifically associated glycogen-
immobilized proteins. The sample was thoroughly mixed
and recentrifuged at 400 000 g for 30 minutes at 4°C. The
supernatant containing malto-oligosaccharide-solubilized
glycogen-associated proteins (SN3, Figure 1) was either
stored at −20°C or treated immediately by addition of 20 μg
TPCK-treated trypsin (Trypsin Gold, Promega, Madison,
WI) and incubated at 37°C for 16 h. Tryptic peptides were
desalted and purified by C18 ZipTip™ desalting columns
(Millipore, Billerica, MA), eluted with 10 μl of 50% metha-
nol, 0.5% acetic acid and 2 μl acetonitrile.
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cates, were used in this study. As a comparison, an add-
itional 3 tryptic digests were conducted on the final
malto-oligosaccharide-washed glycogen pellet using the
conditions described above. All buffers and solutions
were passed through a Sep-Pak reversed-phase tC18
solid-phase extraction column (Waters, Milford, MA) to
remove contaminating peptides and large organic com-
pounds prior to analysis by mass spectrometry.
Mass spectrometry
Tryptic preparations of glycogen-associated proteins were
analyzed by LC/MS/MS using an ESI Ion-Trap/FTMS hy-
brid mass spectrometer (LTQ-FT, ThermoElectron, Corp.,
Waltham, MA). Five percent of each sample was injected
onto a nano-LC column (75 μm ID × 10 cm, Atlantis
dC18 RP, 3μm particle size, Waters Corp.) using a nano-
LC system (NanoLC, Eksigent Technologies, Dublin, CA)
with a gradient of 9% to 60% acetonitrile in 0.1% formic
acid at 400 nL/min (Additional file 1: Table S1). Primary
mass spectra were acquired in the FTMS (FT-ICR) por-
tion of the instrument and MS/MS sequence information
was collected in the linear ion trap using collision-induced
dissociation (CID) to fragment peptides. Primary mass
spectra were acquired with typically better than 2 ppm
mass error; CID spectra were typically acquired with less
than 0.3 Da mass error.
Data analysis
Peaklists (i.e. DTA files) for database searching were
generated for peptide precursor ions (i.e. +1, +2, and/or
+3 charge states) and corresponding CID fragmentation
data using SEQUEST (BioWorks Browser, revision 3.2,
ThermoElectron Corp.) with the default parameters.
Resulting DTA files from each sample acquisition were
combined for each study group and analyzed using
MASCOT (software version 2.1.03, Matrix Science, Inc.,
Boston, MA). The dataset of malto-oligosaccharide-
solubilized glycogen-associated proteins had 26,102
queries, with 11,070 queries occurring in the control
maltodextrin-insoluble glycogen pellet preparation.
Both datasets were searched using the “mammalia” tax-
onomy classification within the MSDB database (down
loaded 08/06/2007, with 3239079 sequences, 339491
after restricting to the “mammalia” taxonomy). The
“mammalia” taxonomy was employed in order to detect
contamination from human keratins and porcine tryp-
sin. It was also sufficiently large to provide a good esti-
mate of the false discovery rate (FDR). The following
MASCOT search parameters were used in the analysis:
tryptic-specific peptides, maximum of 3 missed cleav-
ages, mass tolerances of 5 ppm for precursor ions and
0.3 Da for MS/MS CID fragment ions, no fixed modifi-
cations, and variable oxidation (M), phosphorylation(STY) and O-linked N-acetylglucosamine (ST). No phos-
phorylated or glycosylated peptide were identified in the
final dataset. A significance threshold of p < 0.05 for identi-
fied proteins was used. All individually identified peptides
with expectation scores above 0.05 were excluded. Both pa-
rameters are appropriate as being equivalent to statistical
significance [67]. To gain a conservative estimate of the
false discovery rate (FDR) a decoy database was developed
by the MASCOT software. The FDR is calculated as the
number of false positives (FP), determined by searching the
decoy database, divided by the number of matches (M) in
the target “mammalia” database (FDR = FP/M). The decoy
database consisted of random sequences, of the same
length and average amino acid distribution of the “mam-
malia” database, generated for each identified peptide. The
same criteria for acceptance was employed for both target
and decoy databases. Searches of the mammalian database
resulted in identification of 2340 peptide sequences from
the datasets, which satisfied the Mascot “identity thresh-
old”. Searches of the “decoy” database using the same pa-
rameters based on these datasets resulted in 91 matches,
giving an FDR of 3.8%. Employing the same protocol on
the control maltodextrin-insoluble dataset resulted in 1114
and 77 peptide assignments from the forward and “decoy”
databases respectively, with an FDR of 6.9%. For the
present study, in order for a protein identification to be
considered valid, at least two unique peptides, with differ-
ent primary sequences and expectation scores less than
0.05, were required to be identified from a gene product in
the protein reference database.
In order to achieve consistent protein assignment, the
Mascot search results were exported in the comma-
delimited CSV format and arrayed in a spreadsheet
(Microsoft W Excel W 2004 for Mac Version 11.3.7). Peptides
from poorly annotated protein assignments were submitted
to the International Protein Index (IPI) mouse or rat data-
base (April 2008) using the PROWL website (http://prowl.
rockefeller.edu). The Swiss-Prot identifier was obtained and
submitted to the UNIPROT database (http://www.uniprot.
org) since it is the most annotated. The resulting UNIPROT
entries were used to assign identifiers and obtain sub-
cellular distribution data for each identified gene product.Additional file
Additional file 1: Table S1. The Adipocyte Glycogen Proteome.Abbreviations
ACN: Acetonitrile; AMPK: AMP-activated protein kinase; CBM20: Carbohydrate
binding module_family 20; CBM48: Carbohydrate binding module_family 48;
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emPAI: Exponentially modified Protein Abundance Index; FDR: False
Discovery Rate; FP: False Positive; FTMS: Fourier transform mass spectrometry;
G6P: Glucose-6-phosphate; MO: Malto-oligosaccharide; MS: Mass
spectrometry.
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